Part 1 in a series on clinical trials in wound care
For part 2, click here
by Michel H.E. Hermans, MD
To do a Randomized Controlled Trial within a reasonable time frame, the disease to be studied should be common and the patient population large and accessible. In addition, preferably the effect of the treatment should be fast and specific.
In the pharmaceutical environment these circumstances often exist. Nearly 68 million people in the US suffer from hypertension1,2 and it should be easy to find patients for a clinical trial. The study objective is also relatively simple: lowering blood pressure (of course I am simplifying here).